EIF2AK3 and cancer: Moreover, PERKi co-treatment with DT-061 yields similar effects on cellular viability as DT-061 alone, showing that PERK inhibition is unable to prevent a stress response in cancer cells (Supplementary Fig. 2Q—left panel).